NDC 50222-302

ENSTILAR

Calcipotriene And Betamethasone Dipropionate

ENSTILAR is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Leo Pharma Inc.. The primary component is Betamethasone Dipropionate; Calcipotriene Monohydrate.

Product ID50222-302_0b771976-2050-4eef-bc39-3c853c7c0ac2
NDC50222-302
Product TypeHuman Prescription Drug
Proprietary NameENSTILAR
Generic NameCalcipotriene And Betamethasone Dipropionate
Dosage FormAerosol, Foam
Route of AdministrationTOPICAL
Marketing Start Date2015-10-16
Marketing CategoryNDA / NDA
Application NumberNDA207589
Labeler NameLEO Pharma Inc.
Substance NameBETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE
Active Ingredient Strength1 mg/g; ug/g
Pharm ClassesCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50222-302-60

1 CAN in 1 CARTON (50222-302-60) > 60 g in 1 CAN
Marketing Start Date2015-10-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50222-302-60 [50222030260]

ENSTILAR AEROSOL, FOAM
Marketing CategoryNDA
Application NumberNDA207589
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2015-10-16

NDC 50222-302-91 [50222030291]

ENSTILAR AEROSOL, FOAM
Marketing CategoryNDA
Application NumberNDA207589
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-10-16

NDC 50222-302-66 [50222030266]

ENSTILAR AEROSOL, FOAM
Marketing CategoryNDA
Application NumberNDA207589
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2015-10-16

Drug Details

Active Ingredients

IngredientStrength
CALCIPOTRIENE HYDRATE50 ug/g

OpenFDA Data

SPL SET ID:d1193df2-d53f-4342-bd9d-d9cba7c89709
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1716094
  • 1716099

    • Pharmacological Class

    • Vitamin D [CS]
    • Vitamin D Analog [EPC]
    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    Medicade Reported Pricing

    50222030266 ENSTILAR 0.005%-0.064% FOAM

    Pricing Unit: GM | Drug Type:

    50222030260 ENSTILAR 0.005%-0.064% FOAM

    Pricing Unit: GM | Drug Type:

    NDC Crossover Matching brand name "ENSTILAR" or generic name "Calcipotriene And Betamethasone Dipropionate"

    NDCBrand NameGeneric Name
    50222-302ENSTILARcalcipotriene and betamethasone dipropionate
    0781-7165CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEcalcipotriene and betamethasone dipropionate
    45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    45802-989Calcipotriene and Betamethasone Dipropionatecalcipotriene and betamethasone dipropionate
    51672-1402Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    63646-040calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    66993-937Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    66993-938Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    50222-227Taclonexcalcipotriene and betamethasone dipropionate
    50222-501TACLONEXcalcipotriene and betamethasone dipropionate
    73499-001WynzoraCalcipotriene and Betamethasone dipropionate

    Trademark Results [ENSTILAR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ENSTILAR
    ENSTILAR
    79130021 4541093 Live/Registered
    LEO Pharma A/S
    2012-11-20
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.